SSL

The global healthcare company is good shape at the moment, with its two key brands, Durex and Scholl, trading well and a range of new products introduced to the markets earlier this year across both brands.

SSL has also made a move into China, which has yet to fully feed through to the bottom line.

Management expressed some upbeat views last week, saying that it will deliver double-digit growth in operating profits over the next two years.

Andrew Gibson from Galvan Research and Trading says: ‘Back in May, the company reported better than expected results for last financial year. Momentum has carried through to this year, with July’s trading update pleasing the market. Despite the broad market sell-off, the technicals still look bullish for SSL, and the shares are back to a support area. With or without bid interest, the shares look worth a buy’.

ACTION: BUY SSL International • Target: 500p • Stop loss 425p

TIME TARGET: 6 WEEKS